Clinical Trial Update: Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating conversion from tacrolimus to sirolimus in stable kidney transplant recipients on mycophenolic acid (Myfortic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Renal Transplantation

Drugs mentioned

• Mycophenolic acid (mycophenolic acid)
• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: California Pacific Medical Center Research Institute | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2020-10-27